Fig. 7

Evaluation of vaccine peptides based on published T cell responses in COVID-19 patients. A Overview of studies included in the T cell validation dataset. B All regions (up to 40aa) of the SARS-CoV-2 proteome for which at least three of the eight studies observed either a CD4+ or CD8+ T cell response. Fraction of circle fill corresponds to the largest fraction of patients with responses to any epitope in the region for a particular study. Percentage column corresponds to percent of patients with positive response to an epitope in the region as a fraction of patients evaluated. Overlapping vaccine peptides from this study are noted in the right-most column